Ozempic—and 14 other popular prescription drugs—will cost less for Medicare after the U.S. government negotiated lower prices

Joel Habener, a prominent researcher whose work led to the discovery of the protein fragment GLP-1, has passed away at the age of 88. His research was instrumental in the development of significant weight-loss medications such as Ozempic and Wegovy, which have become widely used in treating obesity and diabetes.